Novartis India has informed that pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the meeting of the Board of Directors of the Company is scheduled to be held on Friday, October 27, 2023, to consider and approve the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2023. Pursuant to the 'Code of Conduct to regulate, monitor and report share trading by Designated Persons and their immediate relatives' ('Code') read with the applicable provisions of the SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended, the Trading Window for dealing in shares of the Company by Designated Persons will be closed with effect from Sunday, October 1, 2023 to Sunday, October 29, 2023.
The above information is a part of company’s filings submitted to BSE.